Joint Diseases clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization
open to eligible people ages 40-79
An open label, prospective, two-arm, multicenter, randomized controlled trial comparing SakuraBead genicular artery embolization (GAE) with a control (corticosteroid injection).
at UCLA
Our lead scientists for Joint Diseases research studies include Susie Park, MD.
Last updated: